ReviewJournal of personalized medicine2024

The Safety and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors for Patients with Sarcopenia or Frailty: Double Edged Sword?

Ayami Naito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.